HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Steroid patterns of benign breast disease.

Abstract
We briefly review some biochemical aspects of benign breast disease (BBD), mainly focusing on free and conjugate estrogen content of breast cyst fluid (BCF), also in relation to cyst type. Evidence is reported that high K(+)-type I-cysts clearly associate with low Cl- levels and accumulate significantly higher quantities of dehydroepiandrosterone sulfate (DHAS) and estrone-3-sulfate (E1S). In spite of the limited number of cases, both increasing DHAS and E1S levels correlate with the increment of K+ to Na+ ratio. A positive correlation was also found between DHAS and E1S. Using electrochemical detection (ECD) on-line to high performance liquid chromatography (HPLC) in the reverse phase mode, we also studied the free estrogen profile. We observed that in type I BCF there are significantly increased amounts of free estrone (E1). The E1S to E1 ratio was significantly different in the two cyst subpopulations; again, a positive correlation was found between free and sulfated E1 (r = 0.820, p less than 10(-6). This last, together with other experimental observations, allows us to hypothesize that in BCF a main pathway of steroids should be E1S----E1. Besides, high specific activity of sulfatase, as well as beta-glucuronidase enzymes, has been demonstrated for BBD. Preliminary information is also reported concerning the BCF pattern of free estrogens, including the highly polar ones, i.e., catecholestrogens (CCE) and the parent methoxy (MeO) conjugates, which represent, in BCF, a predominant portion of all free estrogens. Both CCE levels and ratios appear unevenly distributed in the two different cyst types. In addition, some BCFs show very high concentrations of 16 alpha-OH-E1. Further studies are needed to answer the main question: whether estrogen patterns could represent additive parameters to further categorize breast cystic disease (BCD) or whether they are of minor interest to determine patients' risk of developing breast cancer.
AuthorsL Castagnetta, O M Granata, G Brignone, L Blasi, F Arcuri, M Mesiti, A D'Aquino, W Preitano
JournalAnnals of the New York Academy of Sciences (Ann N Y Acad Sci) Vol. 586 Pg. 121-36 ( 1990) ISSN: 0077-8923 [Print] United States
PMID2141455 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Estrogens
  • Estrone
  • Dehydroepiandrosterone
  • Dehydroepiandrosterone Sulfate
Topics
  • Adenofibroma (analysis)
  • Breast Neoplasms (analysis)
  • Chromatography, High Pressure Liquid
  • Dehydroepiandrosterone (analogs & derivatives, analysis)
  • Dehydroepiandrosterone Sulfate
  • Estrogens (analysis)
  • Estrone (analysis)
  • Female
  • Fibrocystic Breast Disease (analysis)
  • Humans
  • Middle Aged

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: